Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:02 AM
Study NCT ID:
NCT05861102
Status:
RECRUITING
Last Update Posted:
2024-12-12
First Post:
2023-05-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-06
First Submit QC Date:
None
Study First Post Date:
2023-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-11
Last Update Post Date:
2024-12-12
Last Update Post Date Type:
ACTUAL